CVS Health Return on Investment 2010-2025 | CVS
Current and historical return on investment (ROI) values for CVS Health (CVS) over the last 10 years.
| CVS Health ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2025-03-31 | $9.62B | $136.15B | 7.06% |
| 2024-12-31 | $8.52B | $136.26B | 6.30% |
| 2024-09-30 | $9.52B | $134.93B | 7.06% |
| 2024-06-30 | $12.38B | $137.75B | 9.18% |
| 2024-03-31 | $12.57B | $131.84B | 9.38% |
| 2023-12-31 | $13.74B | $135.27B | 10.33% |
| 2023-09-30 | $14.03B | $134.29B | 10.81% |
| 2023-06-30 | $6.42B | $134.42B | 5.07% |
| 2023-03-31 | $7.86B | $128.03B | 6.30% |
| 2022-12-31 | $7.95B | $122.25B | 6.41% |
| 2022-09-30 | $6.64B | $121.86B | 5.29% |
| 2022-06-30 | $13.62B | $126.30B | 10.66% |
| 2022-03-31 | $13.28B | $126.20B | 10.26% |
| 2021-12-31 | $13.31B | $127.35B | 10.20% |
| 2021-09-30 | $13.49B | $131.45B | 10.30% |
| 2021-06-30 | $13.68B | $132.86B | 10.46% |
| 2021-03-31 | $14.03B | $130.43B | 10.75% |
| 2020-12-31 | $13.91B | $128.91B | 10.65% |
| 2020-09-30 | $14.42B | $130.66B | 11.04% |
| 2020-06-30 | $14.10B | $131.84B | 10.87% |
| 2020-03-31 | $12.76B | $131.21B | 9.89% |
| 2019-12-31 | $11.99B | $128.87B | 9.36% |
| 2019-09-30 | $9.77B | $127.14B | 7.61% |
| 2019-06-30 | $9.42B | $128.54B | 7.79% |
| 2019-03-31 | $4.72B | $127.89B | 4.17% |
| 2018-12-31 | $4.02B | $129.99B | 3.79% |
| 2018-09-30 | $6.33B | $97.37B | 7.13% |
| 2018-06-30 | $6.25B | $97.18B | 7.92% |
| 2018-03-31 | $9.74B | $100.23B | 14.01% |
| 2017-12-31 | $9.54B | $59.88B | 16.07% |
| 2017-09-30 | $9.43B | $58.25B | 15.72% |
| 2017-06-30 | $9.75B | $59.77B | 16.04% |
| 2017-03-31 | $9.99B | $59.46B | 16.39% |
| 2016-12-31 | $10.39B | $62.45B | 16.84% |
| 2016-09-30 | $10.12B | $61.56B | 16.34% |
| 2016-06-30 | $9.62B | $60.37B | 15.39% |
| 2016-03-31 | $9.53B | $62.30B | 15.98% |
| 2015-12-31 | $9.48B | $63.47B | 16.85% |
| 2015-09-30 | $9.05B | $63.95B | 17.15% |
| 2015-06-30 | $8.96B | $48.77B | 18.21% |
| 2015-03-31 | $8.91B | $48.68B | 17.95% |
| 2014-12-31 | $8.80B | $49.59B | 17.52% |
| 2014-09-30 | $8.70B | $49.82B | 17.21% |
| 2014-06-30 | $8.60B | $50.38B | 17.24% |
| 2014-03-31 | $8.37B | $51.06B | 16.95% |
| 2013-12-31 | $8.04B | $50.78B | 16.57% |
| 2013-09-30 | $8.10B | $47.35B | 17.06% |
| 2013-06-30 | $7.76B | $48.26B | 16.45% |
| 2013-03-31 | $7.50B | $47.56B | 15.99% |
| 2012-12-31 | $7.21B | $46.79B | 15.40% |
| 2012-09-30 | $6.88B | $46.13B | 14.67% |
| 2012-06-30 | $6.65B | $47.12B | 14.06% |
| 2012-03-31 | $6.43B | $47.26B | 13.50% |
| 2011-12-31 | $6.33B | $47.26B | 13.33% |
| 2011-09-30 | $6.12B | $47.65B | 12.95% |
| 2011-06-30 | $6.02B | $48.41B | 12.89% |
| 2011-03-31 | $6.03B | $46.59B | 13.14% |
| 2010-12-31 | $6.14B | $46.35B | 13.55% |
| 2010-09-30 | $6.27B | $45.29B | 13.99% |
| 2010-06-30 | $6.36B | $45.33B | 14.26% |
| 2010-03-31 | $6.46B | $44.15B | 14.63% |
| 2009-12-31 | $6.43B | $44.52B | 14.54% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $75.446B | $372.809B |
| CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $145.316B | 26.95 |
| Elevance Health (ELV) | United States | $64.396B | 8.66 |
| Cencora (COR) | United States | $55.472B | 19.30 |
| DiDi Global (DIDIY) | China | $25.980B | 27.60 |
| Labcorp Holdings (LH) | United States | $21.919B | 17.30 |
| Natera (NTRA) | United States | $18.843B | 0.00 |
| BioMerieux (BMXMF) | France | $17.068B | 0.00 |
| ICON (ICLR) | Ireland | $15.316B | 14.74 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.929B | 0.00 |
| CochLear (CHEOY) | Australia | $13.403B | 0.00 |
| Solventum (SOLV) | United States | $12.763B | 13.51 |
| Medpace Holdings (MEDP) | United States | $12.728B | 33.68 |
| Revvity (RVTY) | United States | $11.202B | 19.44 |
| Viatris (VTRS) | United States | $10.868B | 3.73 |
| Avantor (AVTR) | United States | $9.533B | 13.85 |
| Sonic Healthcare (SKHHY) | Australia | $9.208B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.791B | 17.23 |
| HealthEquity (HQY) | United States | $8.281B | 36.27 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.884B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.109B | 30.08 |
| BrightSpring Health Services (BTSG) | United States | $3.600B | 33.03 |
| Sotera Health (SHC) | United States | $3.489B | 19.82 |
| Surgery Partners (SGRY) | United States | $2.876B | 37.40 |
| Organon (OGN) | United States | $2.592B | 2.75 |
| Concentras Parent (CON) | United States | $2.576B | 14.89 |
| GeneDx Holdings (WGS) | United States | $2.423B | 93.31 |
| Alignment Healthcare (ALHC) | United States | $2.346B | 0.00 |
| Progyny (PGNY) | United States | $1.989B | 43.77 |
| PACS (PACS) | United States | $1.792B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.789B | 35.79 |
| Premier (PINC) | United States | $1.739B | 13.20 |
| Ardent Health (ARDT) | United States | $1.525B | 6.50 |
| Teladoc Health (TDOC) | United States | $1.439B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.228B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.088B | 8.28 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.875B | 300.00 |
| Agilon Health (AGL) | United States | $0.824B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.753B | 7.05 |
| CareDx (CDNA) | United States | $0.712B | 11.12 |
| Embecta (EMBC) | United States | $0.662B | 4.46 |
| Nutex Health (NUTX) | United States | $0.513B | 7.77 |
| So-Young (SY) | China | $0.513B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.506B | 0.00 |
| LifeMD (LFMD) | United States | $0.494B | 0.00 |
| Omada Health (OMDA) | $0.478B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.477B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.467B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.457B | 10.28 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.406B | 0.00 |
| Enhabit (EHAB) | United States | $0.344B | 28.29 |
| Oncology Institute (TOI) | United States | $0.336B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.286B | 0.00 |
| Beauty Health (SKIN) | United States | $0.222B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.204B | 0.00 |
| DocGo (DCGO) | United States | $0.152B | 24.83 |
| Sera Prognostics (SERA) | United States | $0.118B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| KindlyMD (NAKA) | United States | $0.077B | 0.00 |
| Biodesix (BDSX) | United States | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.042B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.041B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |